UNSPSC 85705251: Replacement of left tarsal with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left tarsal with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QRM3KZ

UNSPSC 85705251 Replacement of left tarsal with nonautologous tissue substitute, percutaneous approach is a Commodity code that does not align with the recent state and local procurement activity tagged to it. The recent opportunities posted under this code include independent medical evaluation services for pension disability determinations, surgical benefit carve-out programs for municipal employee health plans, occupational medical surveillance for ferry workers, emergency and specialty medical services for youth in custody, pharmacy benefit management administration, and temporary health professional staffing. None of these solicitations involve tarsal replacement procedures or orthopedic implant services; instead, the postings span medical administration, workforce health screening, and employee benefit program management. The mismatch suggests either a classification error in the source data or a systematic misalignment between the nominal code and how state and local procurement offices are tagging related healthcare management opportunities.

The issuing bodies represent a mix of municipal, county, and state health systems and administrative agencies: the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and County of Santa Clara Health System. Geographic spread includes Arizona, California, Washington, Texas, and Florida. Because the code shows no recent activity aligned with its stated scope—replacement tarsal procedures with nonautologous tissue substitutes—there is no meaningful pursuit signal at this time. Vendors in orthopedic implant, surgical supply, or tissue engineering should monitor whether state and local procurement offices begin tagging orthopedic device and implant RFQs and RFPs under this code in future cycles, but current activity offers no actionable opportunity.